Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 8;10(1):5.
doi: 10.1186/s40792-023-01802-9.

Gastric inflammatory myofibroblastic tumor presented with severe anemia and inflammation: a case report

Affiliations

Gastric inflammatory myofibroblastic tumor presented with severe anemia and inflammation: a case report

Sakura Hiramatsu et al. Surg Case Rep. .

Abstract

Background: Inflammatory myofibroblastic tumor (IMT) is a rare stromal tumor, often found in children and young adults, and most commonly occurs in the lungs. Surgical resection is considered the standard treatment for localized IMT, although only limited data exist. Gastric IMT in adults is extremely rare, and there are no established guidelines for its treatment.

Case presentation: A 69-year-old male presented with persistent fatigue and weakness. Laboratory examination revealed severe anemia and inflammation. Upper gastrointestinal endoscopy at admission revealed a 40-mm type I softish tumor in the lesser curvature of the gastric body, without apparent hemorrhage. Repeated biopsies, including partial resection with snare, failed to give a definitive diagnosis. Computed tomography (CT) revealed a massive lesion at the gastric body, protruding into the gastric lumen, which was consistent with the gastric tumor. After admission, the patient developed anemia refractory to frequent blood transfusions despite the absence of apparent gastrointestinal bleeding. In addition, the patient had recurrent fevers of 38 °C or higher, and persistent high inflammatory levels. Fluorodeoxyglucose-positron emission tomography (FDG-PET) CT 1 month after the first visit exhibited an increased FDG uptake in the gastric tumor. In addition, this CT scan revealed a rapid increase in tumor size to 75 mm. It was suspected that the undiagnosed gastric tumor caused these serious clinical symptoms, and he underwent distal gastrectomy and cholecystectomy. The gross image of the tumor showed an 80-mm cauliflower-like shape with a gelatinous texture. The histopathological diagnosis was IMT. The postoperative course was uneventful, and the patient's symptoms subsided drastically, improving both anemia and systemic inflammation. The patient has shown no recurrence or relapse of the symptoms over one and a half years.

Conclusions: In this case, the tumor resection finally enabled the diagnosis of IMT and resolved the clinical symptoms. Despite its predominantly benign morphological nature, some cases of IMT present clinically adverse courses. Surgical treatment may lead to its final diagnosis and improvement of clinical symptoms.

Keywords: Anemia; Gut; Inflammation; Inflammatory myofibroblastic tumor; Surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
A Upper gastrointestinal endoscopy at admission revealed a 40-mm type I softish tumor in the lesser curvature of the gastric antrum, without apparent tumor hemorrhage. B Bloc biopsy was performed. The tumor section was gelatinous. C Contrast-enhanced computed tomography (CT) showed a massive lesion at the gastric body, protruding into the gastric lumen (arrows). D Fluorodeoxyglucose-positron emission tomography (FDG-PET) CT one month after the first visit exhibited an FDG uptake in the gastric body (maximum standardized uptake value 8)
Fig. 2
Fig. 2
The left side is the contrast-applied image of the right-side image. A Endoscopic ultrasound showed heterogeneous internal echoes with partially mottled areas (arrows). B Applied contrast revealed rapid blood flow from the vessels at the stem (arrowheads), clarifying its internal structure
Fig. 3
Fig. 3
A The gross image of the tumor showed an 80-mm cauliflower-like shape with a gelatinous texture. B The stem of the semipeduncurated tumor (arrowheads)
Fig. 4
Fig. 4
A The gross image of the tumor showed an 80-mm cauliflower-like shape with a gelatinous texture. B Histopathological examination demonstrated proliferation of spindle cells and collagen fiber, and the infiltration of plasma cells and lymphocytes (HE, × 40). C The myxoid change decreased toward the central region, and inflammatory cell infiltration, including neutrophils, increased instead (HE, × 100). D ALK expression was negative (ALK, × 400). HE hematoxylin eosin, ALK anaplastic lymphoma kinase
Fig. 5
Fig. 5
Clinical course of the present case. CRP C-reactive protein, Hb hemoglobin, RBC2U, transfusion of two units of packed red blood cells

Similar articles

References

    1. Gros L, Dei Tos AP, Jones RL, Digklia A. Inflammatory myofibroblastic tumour: state of the art. Cancers. 2022;14:3662. doi: 10.3390/cancers14153662. - DOI - PMC - PubMed
    1. Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4:889–895. doi: 10.1158/2159-8290.CD-14-0377. - DOI - PMC - PubMed
    1. Zeng X, Huang H, Li J, Peng J, Zhang J. The clinical and radiological characteristics of inflammatory myofibroblastic tumor occurring at unusual sites. Biomed Res Int. 2018;2018:e5679634. doi: 10.1155/2018/5679634. - DOI - PMC - PubMed
    1. Tokunaga K, Maeda C, Horikawa S, Nakayama R, Umeoka S. 18F-FDG PET/CT Imaging of G-CSF–Producing Inflammatory Myofibroblastic Tumor of the Pleura. Clin Nucl Med. 2023;48:e84. doi: 10.1097/RLU.0000000000004457. - DOI - PubMed
    1. Chen W-C, Jiang Z-Y, Zhou F, Wu Z-R, Jiang G-X, Zhang B-Y, et al. A large inflammatory myofibroblastic tumor involving both stomach and spleen: a case report and review of the literature. Oncol Lett. 2015;9:811–815. doi: 10.3892/ol.2014.2761. - DOI - PMC - PubMed

LinkOut - more resources